You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 882 Timing and sequencing of AR-specific vaccination combined with androgen deprivation therapy affect anti-tumor responses in murine prostate cancer models

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
882 Timing and sequencing of AR-specific vaccination combined with androgen deprivation therapy affect anti-tumor responses in murine prostate cancer models
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address